Theralase Technologies Inc. (TLT.V)
CAD 0.27
(0.0%)
CAD 0.27
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.25 Million CAD | 11.86% |
| 2022 | -4.9 Million CAD | -15.2% |
| 2021 | -4.31 Million CAD | 20.26% |
| 2020 | -5.55 Million CAD | 25.39% |
| 2019 | -7.14 Million CAD | -128.15% |
| 2018 | -3.14 Million CAD | 46.33% |
| 2017 | -5.83 Million CAD | -22.82% |
| 2016 | -4.75 Million CAD | 6.66% |
| 2015 | -5.11 Million CAD | -104.05% |
| 2014 | -2.49 Million CAD | -144.59% |
| 2013 | -1.02 Million CAD | 28.7% |
| 2012 | -1.43 Million CAD | -1.58% |
| 2011 | -1.39 Million CAD | -27.84% |
| 2010 | -1.06 Million CAD | -1559.17% |
| 2009 | -60.38 Thousand CAD | 87.6% |
| 2008 | -922.09 Thousand CAD | 42.36% |
| 2007 | -965.89 Thousand CAD | -651.75% |
| 2006 | -387.76 Thousand CAD | -199.39% |
| 2005 | 124.06 Thousand CAD | 49.07% |
| 2004 | 81.66 Thousand CAD | 268.98% |
| 2003 | -50.76 Thousand CAD | -4.68% |
| 2002 | -48.36 Thousand CAD | -111.67% |
| 2001 | 403.03 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.39 Million CAD | -30.67% |
| 2024 Q2 | -1.07 Million CAD | 11.05% |
| 2023 Q2 | -1.08 Million CAD | 18.18% |
| 2023 Q3 | -1 Million CAD | 7.92% |
| 2023 Q4 | -929.12 Thousand CAD | 7.38% |
| 2023 FY | - CAD | 11.86% |
| 2023 Q1 | -1.33 Million CAD | -67.93% |
| 2022 Q1 | -1.64 Million CAD | -37.66% |
| 2022 Q2 | -1.15 Million CAD | 29.9% |
| 2022 Q3 | -1.29 Million CAD | -12.4% |
| 2022 FY | - CAD | -15.2% |
| 2022 Q4 | -792.9 Thousand CAD | 38.83% |
| 2021 Q1 | -985.41 Thousand CAD | -22.75% |
| 2021 Q2 | -1.06 Million CAD | -7.91% |
| 2021 Q3 | -998.8 Thousand CAD | 6.07% |
| 2021 Q4 | -1.19 Million CAD | -19.66% |
| 2021 FY | - CAD | 20.26% |
| 2020 Q4 | -802.75 Thousand CAD | 41.77% |
| 2020 Q3 | -1.37 Million CAD | 11.58% |
| 2020 Q2 | -1.55 Million CAD | 1.32% |
| 2020 Q1 | -1.58 Million CAD | 46.25% |
| 2020 FY | - CAD | 25.39% |
| 2019 Q3 | -1.71 Million CAD | -22.16% |
| 2019 FY | - CAD | -128.15% |
| 2019 Q1 | -1.06 Million CAD | -57.14% |
| 2019 Q2 | -1.4 Million CAD | -31.64% |
| 2019 Q4 | -2.93 Million CAD | -71.05% |
| 2018 Q3 | -664.89 Thousand CAD | 20.19% |
| 2018 FY | - CAD | 46.33% |
| 2018 Q4 | -680.06 Thousand CAD | -2.28% |
| 2018 Q1 | -947.57 Thousand CAD | 15.48% |
| 2018 Q2 | -833.13 Thousand CAD | 12.08% |
| 2017 Q4 | -1.12 Million CAD | 28.96% |
| 2017 Q3 | -1.57 Million CAD | 6.91% |
| 2017 Q2 | -1.69 Million CAD | -18.59% |
| 2017 Q1 | -1.42 Million CAD | -47.65% |
| 2017 FY | - CAD | -22.82% |
| 2016 Q1 | -1.09 Million CAD | -19.16% |
| 2016 Q3 | -1.4 Million CAD | -16.71% |
| 2016 Q4 | -968.19 Thousand CAD | 31.23% |
| 2016 FY | - CAD | 6.66% |
| 2016 Q2 | -1.2 Million CAD | -10.6% |
| 2015 Q1 | -918.35 Thousand CAD | -12.0% |
| 2015 FY | - CAD | -104.05% |
| 2015 Q4 | -915.35 Thousand CAD | 52.71% |
| 2015 Q3 | -1.93 Million CAD | -47.62% |
| 2015 Q2 | -1.31 Million CAD | -42.77% |
| 2014 Q2 | -336.66 Thousand CAD | -12.76% |
| 2014 FY | - CAD | -144.59% |
| 2014 Q1 | -298.55 Thousand CAD | 41.13% |
| 2014 Q3 | -1.03 Million CAD | -207.28% |
| 2014 Q4 | -819.95 Thousand CAD | 20.74% |
| 2013 Q1 | -299.95 Thousand CAD | 39.08% |
| 2013 FY | - CAD | 28.7% |
| 2013 Q4 | -507.14 Thousand CAD | -212.94% |
| 2013 Q3 | -162.06 Thousand CAD | -232.43% |
| 2013 Q2 | -48.75 Thousand CAD | 83.75% |
| 2012 Q4 | -492.34 Thousand CAD | -49.17% |
| 2012 Q3 | -330.06 Thousand CAD | -88.08% |
| 2012 Q2 | -175.49 Thousand CAD | 59.87% |
| 2012 Q1 | -437.31 Thousand CAD | -110.58% |
| 2012 FY | - CAD | -1.58% |
| 2011 FY | - CAD | -27.84% |
| 2011 Q4 | -207.66 Thousand CAD | 49.77% |
| 2011 Q1 | -436.78 Thousand CAD | -42.53% |
| 2011 Q2 | -347.44 Thousand CAD | 20.45% |
| 2011 Q3 | -413.41 Thousand CAD | -18.99% |
| 2010 Q3 | -389.61 Thousand CAD | -139.93% |
| 2010 Q4 | -306.44 Thousand CAD | 21.35% |
| 2010 Q2 | -162.38 Thousand CAD | 32.57% |
| 2010 FY | - CAD | -1559.17% |
| 2010 Q1 | -240.82 Thousand CAD | -289.2% |
| 2009 Q1 | -170.88 Thousand CAD | -200.29% |
| 2009 Q2 | 19.14 Thousand CAD | 111.2% |
| 2009 Q4 | 127.28 Thousand CAD | 404.53% |
| 2009 Q3 | -41.79 Thousand CAD | -318.35% |
| 2009 FY | - CAD | 87.6% |
| 2008 Q1 | -303.83 Thousand CAD | 55.7% |
| 2008 Q4 | -56.9 Thousand CAD | 70.76% |
| 2008 Q3 | -194.64 Thousand CAD | -9.52% |
| 2008 Q2 | -177.73 Thousand CAD | 41.5% |
| 2008 FY | - CAD | 42.36% |
| 2007 Q4 | -685.92 Thousand CAD | -341.8% |
| 2007 FY | - CAD | -651.75% |
| 2007 Q1 | -34.69 Thousand CAD | 90.8% |
| 2007 Q2 | -51.05 Thousand CAD | -47.14% |
| 2007 Q3 | -155.25 Thousand CAD | -204.11% |
| 2006 Q2 | 95.13 Thousand CAD | -17.04% |
| 2006 FY | - CAD | -199.39% |
| 2006 Q4 | -377.3 Thousand CAD | -953.96% |
| 2006 Q1 | 114.68 Thousand CAD | 126.15% |
| 2006 Q3 | 44.18 Thousand CAD | -53.56% |
| 2005 FY | - CAD | 49.07% |
| 2005 Q2 | 55.28 Thousand CAD | 691.48% |
| 2005 Q3 | 11.08 Thousand CAD | -79.95% |
| 2005 Q4 | 50.71 Thousand CAD | 357.55% |
| 2005 Q1 | 6985.00 CAD | -94.73% |
| 2004 Q3 | -11.84 Thousand CAD | 71.37% |
| 2004 Q2 | -41.38 Thousand CAD | -1480.32% |
| 2004 FY | - CAD | 268.98% |
| 2004 Q4 | 132.62 Thousand CAD | 1219.53% |
| 2004 Q1 | 2998.00 CAD | 123.71% |
| 2003 Q2 | -10.66 Thousand CAD | 11.78% |
| 2003 Q1 | -12.08 Thousand CAD | -17.4% |
| 2003 FY | - CAD | -4.68% |
| 2003 Q4 | -12.64 Thousand CAD | 21.35% |
| 2003 Q3 | -16.07 Thousand CAD | -50.75% |
| 2002 Q1 | -11.79 Thousand CAD | 0.0% |
| 2002 Q4 | -10.29 Thousand CAD | 35.48% |
| 2002 FY | - CAD | -111.67% |
| 2002 Q3 | -15.95 Thousand CAD | -39.43% |
| 2002 Q2 | -11.44 Thousand CAD | 2.98% |
| 2001 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -17.91 Million CAD | 76.259% |
| Therma Bright Inc. | -3.67 Million CAD | -15.64% |
| VentriPoint Diagnostics Ltd. | -4.73 Million CAD | 10.222% |